Ibex Biosciences
MD - CumberlandBiotechnology
Focus: Ibex Biosciences is a Maryland-based biotechnology company founded in 2015, specializing in gene therapy and cell therapy modalities. As a publicly-traded entity, it operates in the advanced biologics space with a focus on transformative therapeutic approaches.
Profile data last refreshed 6h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Ibex Biosciences?
AI assessmentCareer fit is high for early-stage biotech specialists willing to accept execution risk; limited hiring and opaque pipeline suggest this is a build-or-rebuild moment rather than a stable growth environment.
Why Work Here
- Exposure to high-impact therapeutic modalities (gene therapy, cell therapy) with significant unmet medical need and long-term growth potential.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Interview Prep Quick Facts
Help build intelligence for Ibex Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.